Ocimum Biosolutions Inc. Closes $8 Million to Fuel Future Growth

Published: Dec 09, 2010

Gaithersburg, Maryland, USA and Hyderabad, Andhra Pradesh, India, December 09, 2010: Ocimum Biosolutions today announced its growth plans after having closed funding worth $8 million from multiple sources, including founders and existing shareholders, in order to cater to the growing demand for its integrated genomic services and to provide unparalleled, hassle-free user experience by enhancing its RaaS (Research as a Service) platform. The company is in the process of building a state-of –the art integrated campus in Patancheru, Hyderabad. Part of the funds will go into completing this 360,000 sq ft facility spread across four blocks. This sprawling four acre campus housing the GLP compliant, genomic and diagnostics labs is scheduled for move in by March 2011.

Ocimum also intends to widen its solution offerings to encompass the entire drug discovery value chain and live up to the vision of enabling R&D by being a one-stop solution provider for every conceivable genomic need. In an effort to achieve that Ocimum will add new offerings in the clinical trial support services, biomarker discovery and biobanking this year and also build capabilities that can broaden its market reach further.

About Ocimum Biosolutions

Ocimum Biosolutions is an leading integrated global genomics outsourcing partner with solutions spanning Bioresearch Design and Execution; Data Analytics and Insights; Laboratory, Sample & Data Management; and Integrated Solutions. Ocimum provides comprehensive genomic services and reference databases; data analysis; biorepository services such as sample accrual & collection, IRB approvals, CRO training, sample, clinical data capture and management; life science lab information management solutions; and also offers both research level and GLP-compliant services. Majority of the top 25 pharma & biotech companies and leading research institutes worldwide have chosen Ocimum as their preferred genomics outsourcing partner.

For more information, please visit www.ocimumbio.com.

Back to news